Literature DB >> 35819502

Socially assistive robots on the market : Experiences from inpatient care and potentials for care at home.

Christoph Strünck1, Verena Reuter2, Vera Gerling2, Pia-Saskia Berg2, Anja Ehlers2.   

Abstract

BACKGROUND: The article addresses commercial socially assistive robots (SAR). There is evidence of the impact of SAR on older persons in institutional settings. Family care at home has not yet been the subject of systematic research; however, especially at home SAR could help to prevent loneliness, provide emotional support, and foster communication.
OBJECTIVE: Inspired by evidence on the potential impact of SAR, the article analyzes their potential for supporting family care at home. A participatory research and development (R&D) project stands as an example of how SAR can improve communication and relations at home.
MATERIAL AND METHODS: Apart from the results of selected randomized controlled trials (RCT) in institutional settings, the article provides results from tests that were run in the R&D project.
RESULTS: SAR can increase the quality of life of users at home. They are capable of improving relations within family care. They inspire communication, change routines, and provide relief to family caregivers; however, it takes trained human companions to support the use of SAR at home and address ethical aspects.
CONCLUSION: If SAR are supposed to deliver their potential for care at home, older persons and their caregivers must be actively involved in research and development. These processes must be systematically evaluated.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Ethics; Family caregivers; Home care; Human companions; Quality of life

Mesh:

Year:  2022        PMID: 35819502     DOI: 10.1007/s00391-022-02087-7

Source DB:  PubMed          Journal:  Z Gerontol Geriatr        ISSN: 0948-6704            Impact factor:   1.292


  10 in total

1.  Therapeutic effects of dog visits in nursing homes for the elderly.

Authors:  Karen Thodberg; Lisbeth Uhrskov Sørensen; Janne Winther Christensen; Pia Haun Poulsen; Birthe Houbak; Vibeke Damgaard; Ingrid Keseler; David Edwards; Poul B Videbech
Journal:  Psychogeriatrics       Date:  2015-10-29       Impact factor: 2.440

2.  Effectiveness of a social robot, "Paro," in a VA long-term care setting.

Authors:  Geoffrey W Lane; Delilah Noronha; Alexandra Rivera; Kathy Craig; Christina Yee; Brent Mills; Eimee Villanueva
Journal:  Psychol Serv       Date:  2016-05-19

3.  Group activity with Paro in nursing homes: systematic investigation of behaviors in participants.

Authors:  Nina Jøranson; Ingeborg Pedersen; Anne Marie Mork Rokstad; Geir Aamodt; Christine Olsen; Camilla Ihlebæk
Journal:  Int Psychogeriatr       Date:  2016-03-28       Impact factor: 3.878

4.  The psychosocial effects of a companion robot: a randomized controlled trial.

Authors:  Hayley Robinson; Bruce Macdonald; Ngaire Kerse; Elizabeth Broadbent
Journal:  J Am Med Dir Assoc       Date:  2013-03-30       Impact factor: 4.669

5.  Animal-assisted therapy and loneliness in nursing homes: use of robotic versus living dogs.

Authors:  Marian R Banks; Lisa M Willoughby; William A Banks
Journal:  J Am Med Dir Assoc       Date:  2008-03       Impact factor: 4.669

Review 6.  Scoping review on the use of socially assistive robot technology in elderly care.

Authors:  Jordan Abdi; Ahmed Al-Hindawi; Tiffany Ng; Marcela P Vizcaychipi
Journal:  BMJ Open       Date:  2018-02-12       Impact factor: 2.692

Review 7.  Effectiveness of Companion Robot Care for Dementia: A Systematic Review and Meta-Analysis.

Authors:  Li-Chin Lu; Shao-Huan Lan; Yen-Ping Hsieh; Long-Yau Lin; Shou-Jen Lan; Jong-Chen Chen
Journal:  Innov Aging       Date:  2021-04-24

8.  Can a humanoid social robot stimulate the interactivity of cognitively impaired elderly? A thorough study based on computer vision methods.

Authors:  Gauri Tulsulkar; Nidhi Mishra; Nadia Magnenat Thalmann; Hwee Er Lim; Mei Ping Lee; Siok Khoong Cheng
Journal:  Vis Comput       Date:  2021-07-30       Impact factor: 2.601

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.